These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38286403)

  • 1. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway.
    Sun Z; Zhang M; Ye Y; Yang L
    Horm Metab Res; 2024 May; 56(5):381-391. PubMed ID: 38286403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
    Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Zheng H; Fu Q; Ma K; Shi S; Fu Y
    Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
    Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
    Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Ma J; Kan Z
    Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.
    Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
    Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways.
    Yang Y; Ding L; Li Y; Xuan C
    J Cell Physiol; 2020 Feb; 235(2):1321-1329. PubMed ID: 31270819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis.
    Zhang F; Li J; Xu J; Jiang X; Chen S; Nasser QA
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):323. PubMed ID: 38914806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
    Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
    Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0010023 promotes the development of papillary thyroid carcinoma by sponging miR-1250-5p.
    Wang L; Wang Y; Wu W; Qian L; Jin P
    Endocrine; 2024 Nov; 86(2):744-752. PubMed ID: 38914746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
    Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
    Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [circ_BACH2 affects the malignant biological behavior of papillary thyroid cancer by regulating miR-370-3p].
    Sun P; Feng Y; Zhou LZ; Pei F; Su B; Qiao XC
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):663-675. PubMed ID: 39034802
    [No Abstract]   [Full Text] [Related]  

  • 14. Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis.
    Wang Y; Zong H; Zhou H
    Bioengineered; 2021 Dec; 12(1):1484-1494. PubMed ID: 33926347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
    Yao Y; Chen X; Yang H; Chen W; Qian Y; Yan Z; Liao T; Yao W; Wu W; Yu T; Chen Y; Zhang Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):318. PubMed ID: 31324198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circ_0005273 promotes thyroid carcinoma progression by SOX2 expression.
    Zhang W; Zhang H; Zhao X
    Endocr Relat Cancer; 2020 Jan; 27(1):11-21. PubMed ID: 31693489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
    Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
    Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0058129 regulates papillary thyroid cancer development via miR-873-5p/follistatin-like 1 axis.
    Tan X; Zhao J; Lou J; Zheng W; Wang P
    J Clin Lab Anal; 2022 May; 36(5):e24401. PubMed ID: 35373391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.